Expression of p53 and Bcl-2 in squamous-cell carcinoma of the head and neck: An immunohistochemical study

Applied Immunohistochemistry

Volumn 6, Issue 2, 1998, Pages 77-83

  Ma, Li ^a   Ronai, Adam ^a   Riede, Ursus N ^a   Köhler, Gabriele ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Carcinogenesis; Head and neck cancer; Immunohistochemistry; Premalignant lesion

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

EID: 0031862459     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-199806000-00004     Document Type: Article

References (20)

1. Lane DP. p53 and human cancers. Br Med Bull 1994;50:582-99.
2. Raybaud-Diogene H, Tetu B, Morency R, et al. p53 over-expression in head and neck squamous cell carcinoma: review of the literature. Oral Oncol Eur J Cancer 1996;32B:143-93.
3. Krajewski S, Tanaka S, Takayama S, et al. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 1993;53:4701-4.
4. Hague A, Moorghen M, Hicks D, et al. Bcl-2 expression in human colorectal adenomas and carcinomas. Oncogene 1994;9:3367-70.
5. Krajewska M, Krajewski S, Epstein JI, et al. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. Am J Pathol 1996;148:1567-76.
6. Silvestrini R, Veneroni S, Daidone MO, et al. The bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymphnode-negative breast cancer patients. J Natl Cancer Inst 1994;86:499-504.
7. Herod JJO, Eliopoulos AG, Warwick J, et al. The prognostic significance of bcl-2 and p53 expression in ovarian carcinoma. Cancer Res 1996;56:2178-84.
8. Fontanini G, Vignati S, Bigini D, et al. Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer. Br J Cancer 1995;71:1003-7.
9. Lipponen P, Eskelinen M, Syrjanen K, et al. Expression of tumor-suppressor gene Rb, apoptosis-suppressing protein bcl-2 and c-myc have no independent prognostic value in renal adenocarcinoma. Br J Cancer 1995;71:863-7.
10. Reed JC, Cuddy M, Slabiak T, et al. Oncogenic potential of bcl-2 demonstrated by gene transfer. Nature 1988;336:259-61.
11. McDonnell TJ, Deane N, Platt FM. Deregulated bcl-2 immunoglobulin transgenic mice demonstrate extended B-cell survival and follicular lymphoproliferation. Cell 1989;57:80-8.
12. Chiou SK, Rao L, White E. Bcl-2 blocks p53-dependent apoptosis. Mol Cell Biol 1994;14:2556-63.
13. Miyashita T, Krajewshi S, Krajewska M, et al. Tumour suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogens 1994;9:1799-805.
14. Vora AR, Rodgers S, Parker AJ, et al. An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma. Br J Cancer 1997;76:836-44.
15. Rusch A, Klimstra D, Venkatraman E, et al. Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer. Cancer Res 1995;55:5038-42.
16. Bubendorf L, Sauter G, Moch H, et al. Prognostic significance of bcl-2 in clinically localized prostate cancer. Am J Pathol 1996;148:1557-65.
17. Langlois ME, Lamb J, Eremin O, et al. Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products. J Pathol 1997;182:392-7.
18. Watson AJM, Merritt AJ, Jones LS, et al. Evidence for reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas. Br J Cancer 1996;73:889-95.
19. Allred DC, Clark GM, Elledge R, et al. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 1993;85:200-6.
20. Lauwers GY, Scott GV, Karpeh MS. Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas. Cancer 1995;75:2209-13.